Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of JTT-851 on diabetes as well as to
assess the safety, tolerability, and pharmacokinetics of JTT-851 in type 2 diabetic patients
either treated with metformin or treatment-naïve.